Home > Insider Trading > Filing (0001209191-11-042503)

Filing Details

Accession Number:: 0001209191-11-042503
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-04 17:16:24
Reporting Period:: 2011-08-02

Filing Date:: 2011-08-04
Accepted Time:: 2011-08-04 17:16:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1342821	Jeff Himawan	C/O Horizon Pharma, Inc. 1033 Skokie Blvd., Suite 355 Northbrook IL 60062		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-02	1,431,467	$0.00	1,431,467	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	179,317	$0.00	1,610,784	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	362,366	$9.00	1,973,150	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	330,104	$9.00	2,303,254	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	P	Indirect	See FN

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-08-02	1,431,467	$0.00	1,431,467	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2011-08-02	179,317	$0.00	179,317	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	362,366	$9.00
Series A Preferred Stock	Warrant to Purchase Series A Preferred Stock	Disposition	2011-08-02	67,970	$0.00	67,970	$5.20
Series A Preferred Stock	Warrant to Purchase Series A Preferred Stock	Disposition	2011-08-02	33,985	$0.00	33,985	$5.20
Series A Preferred Stock	Warrant to Purchase Series A Preferred Stock	Disposition	2011-08-02	42,484	$0.00	42,484	$5.20
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	28,630	$0.00	28,630	$12.35
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	14,315	$0.00	14,315	$12.35
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-08-02	17,895	$0.00	17,895	$12.35

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0	2015-10-31	No	4	C	Indirect
0	2016-07-02	No	4	C	Indirect
0	2016-09-25	No	4	C	Indirect
28,630	2015-10-31	No	4	C	Indirect
14,315	2016-07-02	No	4	C	Indirect
17,895	2016-09-25	No	4	C	Indirect

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
The securities are held directly by Essex Woodlands Health Ventures Fund VII, L.P. (the "Fund"). The Reporting Person is a manager of Essex Woodlands Health Ventures VII, L.L.C., which is the general partner of Essex Woodlands Health Ventures VII, L.P., the general partner of the Fund. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.
Automatic conversion, in connection with the Issuer's initial public offering, of warrants to purchase Series A Preferred Stock into warrants to purchase Common Stock. The warrants converted at a rate of 2.374 shares of Series A Preferred Stock to 1 share of Common Stock.
The warrants are immediately exercisable and shall terminate on the earlier of the expiration date referenced herein or the occurence of other specified corporate transactions.